Samsung Biologics reinforces biologic manufacturing and development partnership with MSD

Samsung Biologics has announced it has expanded its strategic alliance with MSD, or Merck as it is known in the US and Canada, with the signing of a memorandum of understanding. The relationship has come into force to streamline process development and clinical material production for small biotech start-ups focusing on novel drugs.

• Source: pharmafile
• 426
• November 1, 2017